Open access
78
Views
19
CrossRef citations to date
0
Altmetric
Original Research
Cost-effectiveness of roflumilast in combination with bronchodilator therapies in patients with severe and very severe COPD in Switzerland
Yevgeniy Samyshkin1 IMS Health, Health Economics and Outcomes Research, London, United KingdomCorrespondence[email protected]
, Michael Schlunegger2 Marketing Specialty Care, Takeda Pharma AG, Pfäffikon, Switzerland
, Susan Haefliger3 Medical Department, Takeda Pharma AG, Pfäffikon, Switzerland
, Sabine Ledderhose3 Medical Department, Takeda Pharma AG, Pfäffikon, Switzerland
& Matthew Radford1 IMS Health, Health Economics and Outcomes Research, London, United Kingdom
Pages 79-87
|
Published online: 30 Jan 2013
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.